Company Financials

Genscript Biotech Corp Financials

United States dollar

business Genscript Biotech Corp Company Profile

Main Stock Listing

OTC: GNNSF

Market Capitalization $4.79 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 1.58
Forward PE
Price to Sales TTM $8.06
Price to Book MRQ $1.09
Enterprise to Revenue 8.17
Enterprise to EBITDA 69.34

Financial Reports as of Dec. 31, 2024

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2024-12-31
Profit Margin 498.22%
Operating Margin 1.56%
Return on Assets TTM 0.13%
Return on Equity TTM -5.46%

Income Statement

Revenue TTM $594,486,016
Revenue per Share TTM $0.28
Quarterly Revenue Growth %
Gross Profit TTM $272,124,992
EBITDA $70,036,000
Net Income to Common TTM $-67,184,000
Diluted EPS TTM $-0.08
Quarterly Earnings Growth YoY %

Balance Sheet

Total Cash MRQ $621,236,992
Total Cash per Share MRQ $0.29
Total Debt MRQ $
Total Debt to Equity MRQ 16.74
Current Ratio MRQ 2.72
Book Value per Share MRQ $2.02

Cash Flow

Operating Cash Flow TTM $75,647,000
Levered Free Cash Flow TTM $-48,477,752

GNNSF Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 2,143,969,983
Float Shares 1,361,582,213
Avg 10 Volume 7
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 36.90%
% Held by Institutions 20.86%

Stock Price Summary

Beta 0.97
Fifty Two Week Low $1.05
Fifty Two Week High $2.20
Fifty Two Week Change 52.27%
Day 50 MA $1.68
Day 200 MA $1.48

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date 2017-06-05
Last Split Factor
Last Split Date